Submissions from 2022
Ticagrelor versus aspirin 2 years after coronary bypass: Observational analysis from the TARGET trial, Alexander Kulik, Amy Abreu, and Viviana Boronat
Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation, Richard Cartledge, Gary Gottlieb, Gilbert Chidiac, and Burak Ilsin
Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial, Alexander Kulik, Viviana Boronat, and Amy Abreu
Submissions from 2020
Impact of lipid levels and high-intensity statins on vein graft patency after CABG: Midterm results of the ACTIVE trial, Alexander Kulik, Amy Abreu, and Viviana Boronat
Submissions from 2019
Early Outcomes After Thoracoabdominal Aortic Aneurysm Repair With Hypothermic Circulatory Arrest, Alexander Kulik
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis, Alexander Kulik